Influenza

Essential Evidence

Last Updated on 2022-06-24 © 2022 John Wiley & Sons, Inc.

Printer Friendly

Authors:
Mark H. Ebell, MD, MS, Professor, College of Public Health, University of Georgia

Editors:
Randall Forsch, MD, MPH, Assistant Professor, University of Michigan
Mark H. Ebell, MD, MS, Professor, College of Public Health, University of Georgia
Kenny Lin, MD, MPH, Professor of Family Medicine, Georgetown University

Overall Bottom Line

  • Yearly influenza vaccination is recommended by ACIP (US) for persons over the age of 6 months. A
  • Patients classically present with rapid onset of fever, cough, chills or rigors, sore throat, and myalgias. A clinical decision rule can be used to identify patients at low, moderate or high risk of influenza. B
  • Rapid antigen tests are most useful during the beginning and end of the flu season. C
  • Treatment is largely supportive; antiviral medications are recommended only if the likelihood of influenza is high and the patient presents within 24 hours of symptom onset. There is no evidence that they reduce serious complications or hospitalization. A
  • Predictors of adverse outcome in the elderly include increased age, previous hospitalization, comorbidities, gender, and number of outpatient visits in the previous year (Table 1). A

References and Additional Resources

References

  1. Friedman MJ, Attia MW. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med 2004;158:391-394.
  2. Talmor D, Jones AE, Rubinson L, et al. Simple triage scoring system predicting death and the need for critical care resources for use during epidemics. Crit Care 2007;35:1251-1256.
  3. Stein J, Louie J, Flanders S, et al. . Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med 2005;46:412-419.
  4. Rodriguez WJ, Schwartz RH, Thorne MM. . Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J 2002;21:193-196.
  5. Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 2006;160:713-718.
  6. Ebell MH, White LL, Casault T. . A systematic review of the history and physical examination to diagnose influenza. J Am Board Fam Pract 2004;17:1-5.
  7. Ebell MH. . Diagnosing and treating patients with suspected influenza. Am Fam Physician 2005;72:1789-1792.
  8. Nicolson A, Toogood AA, Rahim A, Shalet SM. . The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clin Endocrinol (Oxf) 1996;44:311-316.
  9. Coffin SE, Zaoutis TE, Rosenquist AB, et al. . Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007;119:740-748.
  10. Hak E, Wei F, Nordin J, Mullooly J, Poblete S, Nichol KL. . Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004;189:450-458.
  11. Hak E, Verheij TJ, van Essen GA, Lafeber AB, Grobbee DE, Hoes AW. . Prognostic factors for influenza-associated hospitalization and death during an epidemic. Epidemiol Infect 2001;126:261-268.
  12. Connolly AM, Salmon RL, Lervy B, Williams DH. . What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ 1993;306:1452-1454.
  13. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;357:1555-1564.
  14. Guppy MP, Mickan SM, Del Mar CB. "Drink plenty of fluids": a systematic review of evidence for this recommendation in acute respiratory infections. BMJ 2004;328:499-500.
  15. Swingler GH, Zwarenstein M. . Chest radiograph in acute respiratory infections (Cochrane Review). The Cochrane Library 2009 Issue 2. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Chest radiograph in acute respiratory infectionsRead More

  16. Vickers AJ, Smith C. . Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes (Cochrane Review). The Cochrane Library 2007 Issue 1. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Homeopathic Oscillococcinum® for preventing and treating influenza and influenza‐like illnessRead More

  17. Jiang L, Deng L, Wu T. . Chinese medicinal herbs for influenza (Cochrane Review). The Cochrane Library 2007 Issue 1. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Chinese medicinal herbs for influenzaRead More

  18. Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997;337:874-880.
  19. Monto AS, Fleming DM, Henry D, et al. . Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis 1999;180:254-261.
  20. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-1024.
  21. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-1850.
  22. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
  23. Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-313.
  24. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-607.
  25. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-3247.
  26. Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann Intern Med 2004;140:321-329.
  27. Jacobson Vann JC, Szilagyi P. Patient reminder and patient recall systems for improving immunization rates (Cochrane Review). The Cochrane Library 2007 Issue 1. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Patient reminder and recall interventions to improve immunization ratesRead More

  28. James JM, Zeiger RS, Lester MR, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998;133:624-628.
  29. Miller AE, Morgante LA, Buchwald LY, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997;48:312-314.
  30. Hoberman A, Greenberg DP, Paradise JL, et al. . Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003;290:1608-1616.
  31. Bueving HJ, Bernsen RM, de Jongste JC, et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004;169:488-493.
  32. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999;282:137-144.
  33. Belshe RB, Edwards KM, Vesikari T, et al.; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-696.
  34. Belshe RB, Mendelman PM, Treanor J, et al. . The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-1412.
  35. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284:1655-1663.
  36. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-1343.
  37. Hayden FG, Gubareva LV, Monto AS, et al.; Zanamivir Family Study Group. . Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 2000;343:1282-1289.
  38. Peters PH, Jr., Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49:1025-1031.
  39. Welliver R, Monto AS, Carewicz O, et al.; Oseltamivir Post Exposure Prophylaxis Investigator Group. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-754.
  40. Monto AS, Pichichero ME, Blanckenberg SJ, et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis 2002;186:1582-1588.
  41. Gould DJ, Moralejo D, Drey N, Chudleigh JH. . Interventions to improve hand hygiene compliance in patient care (Cochrane Review). The Cochrane Library 2010 Issue 9. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutionsRead More

  42. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93-97.
  43. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000;284:1677-1682.
  44. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003;139:321-329.
  45. http://www.cdc.gov/flu/weekly/weeklyarchives2006-2007/06-07summary.htm U.S. Influenza Season Summary (Centers for Disease Control and Prevention Influenza Surveillance)www.cdc.gov
  46. Jefferson T, Foxlee R, Del Mar C, Dooley L, Ferroni E, Hewak B, Prabhala A, Nair S, Rivetti A. . Interventions for the interruption or reduction of the spread of respiratory viruses (Cochrane Review). The Cochrane Library 2009 Issue 2. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Physical interventions to interrupt or reduce the spread of respiratory virusesRead More

  47. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009;339:b5106.
  48. Chung EY, Huang L, Schneider L. Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 2010;125:e1024-e1030.
  49. Hak E, Wei F, Nordin J, et al. . Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community dwelling elderly persons. J Infect Dis 2004;189:450-458.
  50. Hyang-Mee L, Hang-Mee L, Hoon-Ki P, Hwan-Sik H, Min-Young C, Hyun-Joo P, Sung Hee O, Duck-An K. Diagnostic value of the rapid influenza antigen test for novel influenza A (H1N1). Scand J Infect Dis 2011;43:43-46.
  51. Ebell MH, Afonso AM, Gonzales R, Stein J, Genton B, Senn N. . Development and validation of a clinical decision rule for the diagnosis of influenza. J Am Board Fam Med 2012 Jan-Feb;25:55-62.
  52. Ebell MH, Call M, Shinholser J. . Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract 2013;30:125-133.
  53. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. . Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013;310:1711-1720.
  54. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya IJ, Mahtani KR, Nunan D, Howick J, Heneghan CJ. Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD008965. DOI: 10.1002/14651858.CD008965.pub4.

    Resources

  55. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults (Cochrane Review). The Cochrane Library 2012 Issue 7. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Amantadine and rimantadine for influenza A in adultsRead More

  56. Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD001269. DOI: 10.1002/14651858.CD001269.pub5.

    Resources

  57. Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis (Cochrane Review). The Cochrane Library 2011 Issue 8. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Vaccines for preventing influenza in people with cystic fibrosisRead More

  58. Thomas RE, Lorenzetti DL. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD005188. DOI: 10.1002/14651858.CD005188.pub4.

    Resources

  59. Cheuk DK, Chiang AK, Lee TL, Chan GC, Ha SY. Vaccines for prophylaxis of viral infections in patients with hematological malignancies (Cochrane Review). The Cochrane Library 2011 Issue 3. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Vaccines for prophylaxis of viral infections in patients with hematological malignanciesRead More

  60. Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis (Cochrane Review). The Cochrane Library 2010 Issue 9. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Influenza vaccine for children and adults with bronchiectasisRead More

  61. Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD002733. DOI: 10.1002/14651858.CD002733.pub3.

    Resources

  62. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in the elderly (Cochrane Review). The Cochrane Library 2010 Issue 2. Chichester, UK: John Wiley and Sons, Ltd.

    Resources

    • Cochrane Systematic Reviews

      Vaccines for preventing influenza in the elderlyRead More

  63. Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014;348:g2547.
  64. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014;348:g2545.
  65. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, Martin E, Gurunathan S, Nathan R, Greenberg DP, Tornieporth NG, Decker MD, Talbot HK. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371:635–645.
  66. Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014;371:918–931.
  67. Huang SY, Lee IK, Wang L, Liu JW, Hung SC, Chen CC, Chang TY, Huang WC. Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room. BMC Infect Dis 2014;14:623.
  68. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD005187. DOI: 10.1002/14651858.CD005187.pub5.

    Resources

  69. Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE. Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. CMAJ 2016;188:567–574.
  70. Black S, Nicolay U, Del Giudice G, Rappuoli R. Influence of statins on influenza vaccine response in elderly individuals. J Infect Dis 2016;213:1224–1228.
  71. Rudenko L, Isakova-Sivak I, Naykhin A, Kiseleva I, Stukova M, Erofeeva M, Korenkov D, Matyushenko V, Sparrow E, Kieny MP. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis 2016;16:303–310.
  72. Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M, SNIFFLE-2 Study Investigators. Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study. BMJ 2015;351:h6291.
  73. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2017-18 Influenza Season. MMWR Recomm Rep 2017;66:1–20.
  74. Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang AJ, Li P, Wong TL, Zhang R, Cheung MKS, Leung W, Lau JYN, Fok M, Chen H, Chan KH, Yuen KY. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial. Chest 2017;151:1069–1080.
  75. Dunkle LM, Izikson R, Patriarca P, Goldenthal KL, Muse D, Callahan J, Cox MMJ; PSC12 Study Team. Efficacy of recombinant influenza vaccine in adults 50 years of age or older. N Engl J Med 2017;376:2427–2436.
  76. Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP, Jr., Hoopes J, Lane HC, Hughes MD; Davey RT, IRC003 Study Team. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis 2017;17:1255–1265.
  77. Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C, Dendukuri N, Papenburg J. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med 2017;167:394–409.
  78. Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness in the United States during the 2015-2016 season. N Engl J Med 2017;377:534–543.
  79. Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No.: CD010406. DOI: 10.1002/14651858.CD010406.pub3.

    Resources

  80. Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A, Baloxavir Marboxil Investigators Group. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 2018;379:913–923.
  81. Ebell MH, Afonso AM, Gonzales R, Stein J, Genton B, Senn N. Development and validation of a clinical decision rule for the diagnosis of influenza. J Am Board Fam Med 2012 Jan-Feb;25:55–62.
  82. Walsh LK, Donelle J, Dodds L, Hawken S, Wilson K, Benchimol EI, Chakraborty P, Guttmann A, Kwong JC, MacDonald NE, Ortiz JR, Sprague AE, Top KA, Walker MC, Wen SW, Fell DB. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ 2019;366:l4151.
  83. Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006484. DOI: 10.1002/14651858.CD006484.pub3.

    Resources

  84. Leidner AJ, Murthy N, Chesson HW, Biggerstaff M, Stoecker C, Harris AM, Acosta A, Dooling K, Bridges CB. Cost-effectiveness of adult vaccinations: A systematic review. Vaccine 2019;37:226–234.
  85. Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A. Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink. Ann Rheum Dis 2019;78:1122–1126.
  86. Radonovich LJ Jr, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, Los JG, Krosche AE, Gibert CL, Gorse GJ, Nyquist AC, Reich NG, Rodriguez-Barradas MC, Price CS, Perl TM, ResPECT investigators. N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA 2019;322:824–833.
  87. Chow EJ, Rolfes MA, O'Halloran A, Anderson EJ, Bennett NM, Billing L, Chai S, Dufort E, Herlihy R, Kim S, Lynfield R, McMullen C, Monroe ML, Schaffner W, Spencer M, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study. Ann Intern Med 2020;173:605–613.
  88. Ison MG, Portsmouth S, Yoshida Y, Shishido T, Mitchener M, Tsuchiya K, Uehara T, Hayden FG. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis 2020;20:1204–1214.
  89. Kumar D, Ison MG, Mira JP, Welte T, Hwan Ha J, Hui DS, Zhong N, Saito T, Katugampola L, Collinson N, Williams S, Wildum S, Ackrill A, Clinch B, Lee N. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet Infect Dis 2022;22:718–730.
  90. Ikematsu H, Hayden FG, Kawaguchi K, Kinoshita M, de Jong MD, Lee N, Takashima S, Noshi T, Tsuchiya K, Uehara T. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts. N Engl J Med 2020;383:309–320.